At Vanderbilt University’s Fall Faculty Assembly, Dan Roden, MD, professor of Medicine, Pharmacology and Biomedical Informatics and Senior Vice President for Personalized Medicine, was awarded the Earl Sutherland Prize for Achievement in Research, Vanderbilt’s most prestigious faculty honor for achievement in research.
Roden received the award for his pioneering work focusing on leveraging genetic information to enhance health care outcomes.
Roden has made significant contributions to the genomics of cardiovascular diseases and to pharmacogenomics, which studies how individual genetics influence responses to therapeutic drugs.
His groundbreaking discoveries demonstrating that the same medication can produce different effects in different patients have illuminated the importance of personalized medicine, which tailors treatments to the individual based on factors such as genetic makeup.
Vanderbilt is now a leader in personalized medicine, largely due to the nationally recognized biobank BioVU, founded by Roden. BioVU has set Vanderbilt apart by providing a robust toolkit for researchers to explore human biology through an unbiased, real-world dataset, yielding invaluable insights into human diseases.
